Of note, our experiments, taking advantage of in vitro blockade of the CyPA/EMMPRIN axis by MM284, further highlighted a strong involvement of this axis in TAA of MFS by reverting pro-fibrotic pathways including the secretion of the active form of TGF-β1. The gene discussed is BSG; the disease is Marfan syndrome.